We are live on ! Find out more
HTGM

HTG Molecular Diagnostics

Delisted

HTGM was delisted on the 14th of June, 2023.

18 hedge funds and large institutions have $283K invested in HTG Molecular Diagnostics in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.86% less ownership

Funds ownership: 7.05% → 4.2% (-2.9%)

14% less funds holding

Funds holding: 21 → 18 (-3)

57% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 7

70% less capital inflows, than outflows

Capital inflows: $61.8K | Capital outflows: $205K

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
18
Holders Change
-3
Holders Change %
-14.29%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

HTGM Hedge Fund Activity: Q3 2022 in Review

18 of the 5,833 institutional investors tracked by Wall St. Rank reported a position in HTG Molecular Diagnostics (HTGM) for Q3 2022, worth a combined $283K — down 55% from $622K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of HTGM and 1 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 3 added.

The largest buyer was Virtu Financial, adding an estimated $60.1K. The largest seller was Susquehanna International Group, cutting an estimated $72.6K.

  • 18 institutional investors held HTG Molecular Diagnostics (HTGM) as of Q3 2022, down from 21 in Q2 2022.
  • Funds reported $283K of HTG Molecular Diagnostics stock for Q3 2022, down 55% quarter-over-quarter.
  • 1 fund opened new HTG Molecular Diagnostics positions in Q3 2022 and 4 closed out, a net change of -3 holders.
  • The largest HTG Molecular Diagnostics buyer in Q3 2022 was Virtu Financial, an estimated $60.1K added.
  • The largest HTG Molecular Diagnostics seller in Q3 2022 was Susquehanna International Group, an estimated $72.6K sold.

Based on aggregated 13F filings for Q3 2022.